Skip to content

Characteristics of metabonomics and intestinal microecology in phlegm-dampened polycystic ovary syndrom

Characteristics of metabonomics and intestinal microecology in phlegm-dampened polycystic ovary syndrom

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2000003448
Enrollment
Unknown
Registered
2020-07-02
Start date
2020-07-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome

Interventions

Sponsors

The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Aged 18-40 years; 2.Body mass index > 23Kg/m3; 3.consistent with PCOS diagnosis; 4.consistent with the diagnosis of TCM syndrome differentiation.

Exclusion criteria

Exclusion criteria: 1. In the past three months, people who have taken oral drugs that affect test results, such as antibiotics, birth control pills or other hormone drugs, insulin sensitizers, lipid-lowering drugs, etc. 2. Patients suffering from gastrointestinal diseases (such as diarrhea, enteritis, etc.) or diseases affecting intestinal microecology such as acute infection. 3. Patients with organic diseases of heart, lung, liver, kidney and other important organs or patients with mental disorders and other causes that cannot cooperate with the test.

Design outcomes

Primary

MeasureTime frame
Intestinal flora;Serum metabolomics;Fasting serum insulin;Fasting glucose;

Secondary

MeasureTime frame
androstenedione;Follicle-stimulating hormone;Dehydroepiandrosterone sulfate;Sex hormone binding globulin;testosterone;triglycerides;estradiol;High density lipoprotein;Low density lipoprotein;Luteinizing hormone;Total cholesterol;

Countries

China

Contacts

Public ContactHan Zhang

The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

zyydxzh@163.com+86 18322577855

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026